Pantothenate-kinase-associated neurodegeneration (PKAN) is an autosomal recessive disorder characterized by iron deposits in basal ganglia. The aim of this study was to quantify iron concentrations of deep gray matter structures in heterozygous PANK2 mutation carriers and in PKAN patients using quantitative susceptibility mapping MRI. By determining iron concentration, we intended to find mutation-specific brain parenchymal stigmata in heterozygous PANK2 mutation carriers in comparison to age-matched healthy volunteers. We studied 11 heterozygous PANK2 gene mutation carriers (mean age: 43.4 years; standard deviation [SD]: 10.5), who were found to be clinically asymptomatic by neurological examination. These carriers were compared to 2 clinically affected PKAN patients 21 and 32 years of age and to 13 age-matched, healthy controls (mean age: 39.7; SD, 13.6). Scanning was performed on a 7.0-Tesla whole-body scanner applying three-dimensional susceptibility-weighted gradient echo acquisitions. Susceptibility maps were calculated by threshold-based k-space division with single-orientation acquisition. Magnetic susceptibility values, relative to the occipital white matter, were determined for the following regions of interest (ROI): globus pallidus (GP), thalamus, putamen, internal capsule (IC), caudate nucleus, substantia nigra (SN), and red nucleus. Heterozygous PANK2 mutation carriers did not show increased brain iron concentrations, compared to healthy controls (P > 0.05), in any of the examined ROIs. In PKAN patients, more than 3 times higher concentrations of iron were found in the GP, SN, and IC. Our results suggest that heterozygous mutations in PANK2 gene do not cause brain iron accumulation nor do they cause movement disorders.

Berlin Ultrahigh Field Facility Max Delbrueck Center for Molecular Medicine Berlin Germany

Department of Neurology and Center for Stroke Research Berlin Charité Universitaetsmedizin Berlin Germany

Department of Neurology and Center of Clinical Neuroscience Charles University Prague 1st Faculty of Medicine and General University Hospital Prague Czech Republic

Experimental and Clinical Research Center Charité Universitaetsmedizin and Max Delbrueck Center for Molecular Medicine Berlin Germany

Institute of Neuroradiology University Medicine Goettingen Goettingen Germany

NeuroCure Clinical Research Center Charité University Medicine Berlin Berlin Germany

Neurology Department University of Kiel Kiel Germany

Zobrazit více v PubMed

Kruer MC, Boddaert N, Schneider SA, et al. Neuroimaging features of neurodegeneration with brain iron accumulation. AJNR Am J Neuroradiol 2012;33:407–414. PubMed PMC

Haacke EM, Cheng NY, House MJ, et al. Imaging iron stores in the brain using magnetic resonance imaging. Magn Reson Imaging 2005;23:1–25. PubMed

Delgado RF, Sanchez PR, Speckter H, et al. Missense PANK2 mutation without “eye of the tiger” sign: MR findings in a large group of patients with pantothenate kinase‐associated neurodegeneration (PKAN). J Magn Reson Imaging 2012;35:788–794. PubMed

Hayflick SJ, Hartman M, Coryell J, Gitschier J, Rowley H. Brain MRI in neurodegeneration with brain iron accumulation with and without PANK2 mutations. AJNR Am J Neuroradiol 2006;27:1230–1233. PubMed PMC

Hayflick SJ, Penzien JM, Michl W, Sharif UM, Rosman NP, Wheeler PG. Cranial MRI changes may precede symptoms in Hallervorden‐Spatz syndrome. Pediatr Neurol 2001;25:166–169. PubMed

Chiapparini L, Savoiardo M, D'Arrigo S, et al. The “eye‐of‐the‐tiger” sign may be absent in the early stages of classic pantothenate kinase associated neurodegeneration. Neuropediatrics 2011;42:159–162. PubMed

Aggarwal A, Schneider SA, Houlden H, et al. Indian‐subcontinent NBIA: unusual phenotypes, novel PANK2 mutations, and undetermined genetic forms. Mov Disord 2010;25:1424–1431. PubMed

Dezortova M, Herynek V, Krssak M, Kronerwetter C, Trattnig S, Hajek M. Two forms of iron as an intrinsic contrast agent in the basal ganglia of PKAN patients. Contrast Media Mol Imaging 2012;7:509–515. PubMed

Rulseh AM, Keller J, Tintera J, Kozisek M, Vymazal J. Chasing shadows: what determines DTI metrics in gray matter regions? An in vitro and in vivo study. J Magn Reson Imaging 2013;38:1103–1110. PubMed

Liu J, Liu T, de Rochefort L, et al. Morphology enabled dipole inversion for quantitative susceptibility mapping using structural consistency between the magnitude image and the susceptibility map. Neuroimage 2012;59:2560–2568. PubMed PMC

Marques JP, Bowtell R. Application of a Fourier‐based method for rapid calculation of field inhomogeneity due to spatial variation of magnetic susceptibility. Concepts Magn Reson Part B Magn Reson Eng 2005;25B:65–78.

Salomir R, de Senneville BD, Moonen CTW. A fast calculation method for magnetic field inhomogeneity due to an arbitrary distribution of bulk susceptibility. Concepts Magn Reson 2003;19B:26–34.

Schweser F, Deistung A, Lehr BW, Reichenbach JR. Quantitative imaging of intrinsic magnetic tissue properties using MRI signal phase: an approach to in vivo brain iron metabolism? Neuroimage 2011;54:2789–2807. PubMed

de Rochefort L, Liu T, Kressler B, et al. Quantitative susceptibility map reconstruction from MR phase data using Bayesian regularization: validation and application to brain imaging. Magn Reson Med 2010;63:194–206. PubMed

Wharton S, Schafer A, Bowtell R. Susceptibility mapping in the human brain using threshold‐based k‐space division. Magn Reson Med 2010;63:1292–1304. PubMed

Turner R, Jezzard P, Wen H, et al. Functional mapping of the human visual cortex at 4 and 1.5 Tesla using deoxygenation contrast EPI. Magn Reson Med 1993;29:277–279. PubMed

Meloni A, Hezel F, Positano V, et al. Detailing magnetic field strength dependence and segmental artifact distribution of myocardial effective transverse relaxation rate at 1.5, 3.0, and 7.0 T. Magn Reson Med 2014;71:2224–2230. PubMed

Haacke EM, Xu Y, Cheng YC, Reichenbach JR. Susceptibility weighted imaging (SWI). Magn Reson Med 2004;52:612–618. PubMed

Haacke EM, Tang J, Neelavalli J, Cheng YC. Susceptibility mapping as a means to visualize veins and quantify oxygen saturation. J Magn Reson Imaging 2010;32:663–676. PubMed PMC

Langkammer C, Schweser F, Krebs N, et al. Quantitative susceptibility mapping (QSM) as a means to measure brain iron? A post mortem validation study Neuroimage 2012;62:1593–1599. PubMed PMC

Hallgren B, Sourander P. The effect of age on the non‐haemin iron in the human brain. J Neurochem 1958;3:41–51. PubMed

Binkofski F, Reetz K, Gaser C, et al. Morphometric fingerprint of asymptomatic Parkin and PINK1 mutation carriers in the basal ganglia. Neurology 2007;69:842–850. PubMed

Schneider SA, Talelli P, Cheeran BJ, et al. Motor cortical physiology in patients and asymptomatic carriers of parkin gene mutations. Mov Disord 2008;23:1812–1819. PubMed

Leoni V, Strittmatter L, Zorzi G, et al. Metabolic consequences of mitochondrial coenzyme A deficiency in patients with PANK2 mutations. Mol Genet Metab 2012;105:463–471. PubMed PMC

Hajek M, Adamovicova M, Herynek V, et al. MR relaxometry and 1H MR spectroscopy for the determination of iron and metabolite concentrations in PKAN patients. Eur Radiol 2005;15:1060–1068. PubMed

Fermin‐Delgado R, Roa‐Sanchez P, Speckter H, et al. Involvement of globus pallidus and midbrain nuclei in pantothenate kinase‐associated neurodegeneration: measurement of T2 and T2* time. Clin Neuroradiol 2013;23:11–15. PubMed

Kruer MC, Hiken M, Gregory A, et al. Novel histopathologic findings in molecularly‐confirmed pantothenate kinase‐associated neurodegeneration. Brain 2011;134(Pt 4):947–958. PubMed PMC

Antonini A, Goldwurm S, Benti R, et al. Genetic, clinical, and imaging characterization of one patient with late‐onset, slowly progressive, pantothenate kinase‐associated neurodegeneration. Mov Disord 2006;21:417–418. PubMed

Awasthi R, Gupta RK, Trivedi R, Singh JK, Paliwal VK, Rathore RK. Diffusion tensor MR imaging in children with pantothenate kinase‐associated neurodegeneration with brain iron accumulation and their siblings. AJNR Am J Neuroradiol 2010;31:442–447. PubMed PMC

Kostic VS, Svetel M, Mijajlovic M, Pavlovic A, Jecmenica‐Lukic M, Kozic D. Transcranial sonography in pantothenate kinase‐associated neurodegeneration. J Neurol 2012;259:959–964. PubMed

Shmueli K, de Zwart JA, van Gelderen P, Li TQ, Dodd SJ, Duyn JH. Magnetic susceptibility mapping of brain tissue in vivo using MRI phase data. Magn Reson Med 2009;62:1510–1522. PubMed PMC

Wharton S, Bowtell R. Whole‐brain susceptibility mapping at high field: a comparison of multiple‐ and single‐orientation methods. Neuroimage 2010;53:515–525. PubMed

Cerebral Iron Deposition in Neurodegeneration